-azone
Anti-inflammatory painkillers related to phenylbutazone.
- Drugs ending in -azone: 17
- Approved somewhere: 9
- With a US drug page: 6
- Stem
- -azone
- Class
- Anti-inflammatory painkillers related to phenylbutazone
- Sub-stem of
- -buzone: Anti-inflammatory painkillers related to phenylbutazone
- Most common targets
- SLC12A3 (2), Bacterial penicillin-binding protein (1), DNA (1), SLC22A12 (1), KCNN4 (1), PTGS1, PTGS2 (1), PPARG (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -azone, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Cefoperazone | Approved | Bacterial penicillin-binding protein | Bacterial penicillin-binding protein inhibitor |
| Metolazone | Approved | SLC12A3 | Thiazide-sensitive sodium-chloride cotransporter inhibitor |
| Nitrofurazone | Approved | DNA | DNA inhibitor |
| Quinethazone | Approved | SLC12A3 | Thiazide-sensitive sodium-chloride cotransporter inhibitor |
| Sulfinpyrazone | Approved | SLC22A12 | Solute carrier family 22 member 12 inhibitor |
| Chlorzoxazone | — | KCNN4 | Intermediate conductance calcium-activated potassium channel protein 4 opener |
| Apazone | Approved | PTGS1, PTGS2 | Cyclooxygenase inhibitor |
| Feprazone | Approved | — | Unknown |
| Naftazone | Approved | — | — |
| Propyphenazone | Approved | — | — |
| Mitoguazone | Phase 3 | — | — |
| Cefbuperazone | Phase 2 | — | — |
| Efatutazone | Phase 2 | PPARG | Peroxisome proliferator-activated receptor gamma agonist |
| Methisazone | Phase 2 | — | — |
| Nifenazone | Phase 2 | — | — |
| Proquazone | Phase 2 | — | — |
| Sulfamazone | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO